[Economic evaluation of drug eluting stents for high risk indications]

Martin Saborido C, Blasco Amaro JA, Callejo Velasco D, Lopez-Pedraza Gomez J, Maeso Martinez S
Record ID 32011001548
Authors' objectives:

Review and assess economics studies comparing the use of drug eluting stent versus bare metal and to perform a cost-effectiveness evaluation.

Authors' recomendations: The use of DES in the patients with high risk indications: Lesion in a saphenous by-pass graft, lesion in left main artery totally occluded lesions and restenotic lesion is cost-effective for a 6 months long antiplatelet treatment. The drug eluting stent option could stop being cost-effective varying some of the basal conditions. More studies would be necessary to assess the effectiveness of drug eluting stent in each one of the indications in patients undergone a percutaneous coronary intervention with stent.
Project Status: Completed
Year Published: 2008
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Spain
MeSH Terms
  • Cost-Benefit Analysis
Organisation Name: Unidad de Evaluacion de Tecnologias Sanitarias
Contact Address: Elena Andradas Aragones, Unidad de Evaluacion de Tecnologias Sanitarias, Agencia Lain Entralgo, C/ Gran Via, 27, 8a, ES-28013 Madrid, Spain. Tel: +34 91 3089418; Fax: +34 91 3089458;
Contact Name: elena.andradas@salud.madrid.org
Contact Email: elena.andradas@salud.madrid.org

Unidad de Evaluacion de Tecnologias Sanitarias (UETS)

This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.